NVIDIA (NVDA) Rule 144 Notice: Insider Plans $25.8M Sale

Rhea-AI Filing Summary

Form 144 filed for NVIDIA Corporation (NVDA) discloses a proposed open-market sale of 145,780 shares of common stock through Goldman Sachs & Co. LLC with an aggregate market value of $25,754,952.60, with an approximate planned sale date of 09/19/2025. The filing lists multiple prior acquisitions of the shares as compensation (performance awards and restricted stock units) on dates ranging from 03/19/2019 to 09/17/2025. The table of recent sales shows multiple transactions by related entities and Colette Kress between 06/20/2025 and 08/04/2025 totaling repeated blocks of shares and corresponding gross proceeds. The notice includes the sellers representation about lack of undisclosed material adverse information.

Insights

Financial Analyst

TL;DR: Routine insider liquidity notice: a sale of 145,780 NVDA shares (~$25.8M) scheduled for 09/19/2025.

The filing is a Rule 144 notice indicating planned disposition of vested compensation stock and RSUs through an institutional broker. The schedule of acquisition dates and the separate list of recent sales by related entities provide transparency on when the securities were acquired and recent liquidity events. There is no earnings or operational information in the filing to change a valuation or revenue outlook. The size of the proposed sale is disclosed explicitly but must be assessed versus NVDAs market float to judge market impact; that comparison is not provided in this filing.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure: insider is meeting Rule 144 notice requirements for planned sales of compensation shares.

The document documents acquisitions labeled as compensation and restricted stock units and lists prior open-market sales by the named parties, which supports compliance and insider-trading transparency. The sellers attestation regarding material non-public information is present as required. The filing does not disclose any changes in control, executive departures, or governance actions; it is a routine notification of intended sales under securities rules.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	145780	25754952.6	24400000000	09/19/2025	NASD

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	12/13/2023	Acquired as compensation -- Performance Awards	Issuer			36500	12/13/2023	Compensation
Common Stock	12/13/2023	Acquired as compensation -- Performance Awards	Issuer			935	12/13/2023	Compensation
Common Stock	12/13/2023	Acquired as compensation -- Restricted Stock Units	Issuer			9946	12/13/2023	Compensation
Common Stock	09/17/2025	Acquired as compensation -- Performance Awards	Issuer			2817	09/17/2025	Compensation
Common Stock	09/17/2025	Acquired as compensation -- Performance Awards	Issuer			20073	09/17/2025	Compensation
Common Stock	09/17/2025	Acquired as compensation -- Restricted Stock Units	Issuer			5164	09/17/2025	Compensation
Common Stock	09/17/2025	Acquired as compensation -- Restricted Stock Units	Issuer			2822	09/17/2025	Compensation
Common Stock	09/17/2025	Acquired as compensation -- Restricted Stock Units	Issuer			5842	09/17/2025	Compensation
Common Stock	09/17/2025	Acquired as compensation -- Restricted Stock Units	Issuer			1681	09/17/2025	Compensation
Common Stock	06/21/2023	Acquired as compensation -- Restricted Stock Units	Issuer			29853	06/21/2023	Compensation
Common Stock	09/20/2023	Acquired as compensation -- Performance Awards	Issuer			147	09/20/2023	Compensation
Common Stock	03/19/2019	Acquired as compensation -- Performance Awards	Issuer			30000	03/19/2019	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
CDK 2 LLC 2788 San Tomas Expressway Santa Clara CA 95051	Common Stock	06/20/2025	5000	727904.5
KRESS 2024 NIMCRUT dtd 12/04/2024 2788 San Tomas Expressway Santa Clara CA 95051	Common Stock	06/20/2025	5000	727904.5
Colette Kress 2788 San Tomas Expressway Santa Clara CA 95051	Common Stock	06/20/2025	30500	4387970.95
CDK 2 LLC 2788 San Tomas Expressway Santa Clara CA 95051	Common Stock	06/20/2025	5000	719339.5
KRESS 2024 NIMCRUT dtd 12/04/2024 2788 San Tomas Expressway Santa Clara CA 95051	Common Stock	06/20/2025	5000	719339.5
Colette Kress 2788 San Tomas Expressway Santa Clara CA 95051	Common Stock	07/15/2025	16675	2856100.67
CDK 2 LLC 2788 San Tomas Expressway Santa Clara CA 95051	Common Stock	07/15/2025	5000	856402
KRESS 2024 NIMCRUT dtd 12/04/2024 2788 San Tomas Expressway Santa Clara CA 95051	Common Stock	07/15/2025	5000	856402
Colette Kress 2788 San Tomas Expressway Santa Clara CA 95051	Common Stock	07/15/2025	10975	1869944.65
CDK 2 LLC 2788 San Tomas Expressway Santa Clara CA 95051	Common Stock	07/15/2025	5000	851911
KRESS 2024 NIMCRUT dtd 12/04/2024 2788 San Tomas Expressway Santa Clara CA 95051	Common Stock	07/15/2025	5000	851911
Colette Kress 2788 San Tomas Expressway Santa Clara CA 95051	Common Stock	08/04/2025	10975	1941466.52
CDK 2 LLC 2788 San Tomas Expressway Santa Clara CA 95051	Common Stock	08/04/2025	5000	884495
KRESS 2024 NIMCRUT dtd 12/04/2024 2788 San Tomas Expressway Santa Clara CA 95051	Common Stock	08/04/2025	5000	884495
Colette Kress 2788 San Tomas Expressway Santa Clara CA 95051	Common Stock	08/04/2025	16665	2982456.73
CDK 2 LLC 2788 San Tomas Expressway Santa Clara CA 95051	Common Stock	08/04/2025	5000	894826.5
KRESS 2024 NIMCRUT dtd 12/04/2024 2788 San Tomas Expressway Santa Clara CA 95051	Common Stock	08/04/2025	5000	894826.5

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is being sold according to the NVDA Form 144 filing?

The filing reports a proposed sale of 145,780 shares of NVDA common stock with an aggregate market value of $25,754,952.60 through Goldman Sachs & Co. LLC.

When is the proposed sale date listed in the filing?

The approximate date of sale is listed as 09/19/2025.

How were the shares acquired that are being sold?

The shares were acquired as compensation including performance awards and restricted stock units on dates from 03/19/2019 through 09/17/2025.

Who is the broker named to execute the sale?

The broker named in the filing is Goldman Sachs & Co. LLC, located at 200 West Street, New York, NY 10282.

Does the filing show prior sales by the seller?

Yes. The filing lists multiple prior sales by related entities and Colette Kress between 06/20/2025 and 08/04/2025 with listed amounts and gross proceeds.